Tower International (TOWR) 22.03 $TOWR Tower

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Tower International (TOWR) 22.03 $TOWR

Tower International to Announce Second Quarter 2016 Financial Results
PR Newswire - Mon Jul 18, 4:30PM CDT
Tower International, Inc. (NYSE: TOWR), a leading global manufacturer of engineered automotive structural metal components and assemblies, will report second quarter 2016 financial results before the market opens on Tuesday, July 26, 2016, via PR Newswire. At 10:00 a.m. EDT on that date, a conference call is scheduled to discuss the results in further detail, as well as other related matters.
TOWR: 22.03 (-0.09)

Ford's Europe Sales Up 2.6% in June, 7.4% in First-Half 2016
Zacks Equity Research - Zacks Investment Research - Mon Jul 18, 7:20AM CDT
Ford (F) recorded a 2.6% rise in sales to 130,200 vehicles in its 20 traditional European markets in June and 7.4% to 718,300 vehicles in the first half of 2016.
F: 12.07 (-0.06), PRTS: 3.79 (unch), SPAR: 8.65 (+0.26), TOWR: 22.03 (-0.09)

Zacks.com featured highlights: DeVry Education Group, PharMerica, Trinity Industries, Select Medical and Tower International
Zacks Equity Research - Zacks Investment Research - Fri Jul 08, 8:30AM CDT
Zacks.com featured highlights: DeVry Education Group, PharMerica, Trinity Industries, Select Medical and Tower International
PMC: 26.23 (-0.23), TRN: 22.98 (-0.01), DV: 22.29 (-0.05), TOWR: 22.03 (-0.09), SEM: 10.98 (-0.11)

5 Low Price-to-Cash-Flow Stocks for Assured Returns
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 8:29AM CDT
There are different valuation metrics to determine a stock's inherent strength but a random selection of ratios cannot serve your purpose.
PMC: 26.23 (-0.23), TRN: 22.98 (-0.01), DV: 22.29 (-0.05), SEM: 10.98 (-0.11), TOWR: 22.03 (-0.09)

Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
Zacks Equity Research - Zacks Investment Research - Wed Jun 22, 8:30AM CDT
Zacks.com featured highlights: Dean Foods, PharMerica, Tower International, Ford Motor and Carnival
PMC: 26.23 (-0.23), F: 12.07 (-0.06), CUK: 47.64 (+0.44), DF: 18.29 (-0.21), TOWR: 22.03 (-0.09)

5 Low Price-to-Cash-Flow Stocks with High Return Prospects
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:46AM CDT
Value style is generally considered one of the best practices when it comes to stock picking. For this, we would suggest considering Price to Cash Flow (or P/CF) ratio as one of the key metrics.
PMC: 26.23 (-0.23), F: 12.07 (-0.06), CUK: 47.64 (+0.44), DF: 18.29 (-0.21), TOWR: 22.03 (-0.09)

Zacks Investment Ideas feature highlights: SPX, Delta Apparel, AV Homes, Salem Media and Tower International
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks Investment Ideas feature highlights: SPX, Delta Apparel, AV Homes, Salem Media and Tower International
SALM: 7.33 (+0.13), DLA: 21.93 (-0.61), SPXC: 15.34 (+0.23), AVHI: 13.80 (-0.11), TOWR: 22.03 (-0.09)

Tower International Board Authorizes $100 Million Share Buyback
PR Newswire - Fri Jun 17, 8:00AM CDT
The Board of Directors of Tower International, Inc. (NYSE: TOWR), a leading global manufacturer of engineered automotive structural metal components and assemblies, today authorized management to repurchase up to $100 million of the Company's issued and outstanding common stock from time to time in the open market. The time period for the buyback is open-ended.
TOWR: 22.03 (-0.09)

5 Stocks That Buffett Wishes He Could Buy
Tracey Ryniec - Zacks Investment Research - Thu Jun 16, 4:05PM CDT
5 Stocks That Buffett Wishes He Could Buy
SALM: 7.33 (+0.13), DLA: 21.93 (-0.61), SPXC: 15.34 (+0.23), AVHI: 13.80 (-0.11), TOWR: 22.03 (-0.09)

Tower International (TOWR): Strong Industry, Solid Earnings Estimate Revisions
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:42AM CDT
Tower International (TOWR) looks like an interesting choice for investors, as it is seeing solid estimate revisions and belongs to a great industry.
TOWR: 22.03 (-0.09)

Fight Volatility with These 5 Value Stocks Near 52-Week Lows
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 7:04AM CDT
Stocks trading near 52-week lows can make good bets.
RCII: 11.64 (+0.09), KVHI: 8.88 (-0.15), AMCX: 53.29 (-3.04), MSGN: 15.19 (-0.44), TOWR: 22.03 (-0.09)

The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:30AM CDT
The Zacks Analyst Blog Highlights: JinkoSolar Holding, Carnival, PharMerica, Air Methods and Tower International
PMC: 26.23 (-0.23), AIRM: 31.14 (-0.84), CUK: 47.64 (+0.44), TOWR: 22.03 (-0.09), JKS: 19.19 (+0.16)

Why Tower International (TOWR) is Such a Great Value Stock Pick Right Now
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 6:18AM CDT
Tower International (TOWR) is a strong candidate for an impressive value and could be a great choice for value investors at this time
TOWR: 22.03 (-0.09)

5 Stocks with Impressive Price-to-Cash-Flow Ratio
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:13PM CDT
The strategy is quite simple - find stocks that are trading below their inherent worth.
PMC: 26.23 (-0.23), AIRM: 31.14 (-0.84), CUK: 47.64 (+0.44), TOWR: 22.03 (-0.09), JKS: 19.19 (+0.16)

Will AutoZone (AZO) Surprise Investors with Q3 Earnings?
Zacks Equity Research - Zacks Investment Research - Fri May 20, 6:55AM CDT
AutoZone, Inc. (AZO) is expected to report third-quarter fiscal 2016 (ended May 7, 2016) results on May 24.
SMP: 43.34 (-0.05), AZO: 808.45 (+3.54), WNC: 13.95 (+0.10), TOWR: 22.03 (-0.09)

7 Low Price-to-Cash-Flow Stocks to Fetch Higher Returns
Zacks Equity Research - Zacks Investment Research - Thu May 19, 2:08PM CDT
Investments in stocks made from diligent value analysis is usually considered one of the best practices.
PMC: 26.23 (-0.23), KEP: 27.27 (-0.64), AIRM: 31.14 (-0.84), CUK: 47.64 (+0.44), DF: 18.29 (-0.21), TOWR: 22.03 (-0.09), JKS: 19.19 (+0.16)

Tower posts 1Q profit
Automated Insights - Thu Apr 28, 8:22AM CDT
LIVONIA, Mich. (AP) _ Tower International Inc. (TOWR) on Thursday reported first-quarter net income of $8.4 million.
TOWR: 22.03 (-0.09)

Tower International Reports Solid First Quarter, Raises Full Year 2016 Outlook, and Expects Double-Digit Earnings Growth in 2017, Including Retention of Europe Business
PR Newswire - Thu Apr 28, 7:00AM CDT
Tower International, Inc. (NYSE: TOWR), a leading global manufacturer of engineered automotive structural metal components and assemblies, today announced first quarter 2016 results, updated its outlook for full year 2016, provided a preliminary outlook for 2017, and discussed developments regarding Tower's businesses in Europe, Brazil, and China.
TOWR: 22.03 (-0.09)

Tower International to Announce First Quarter 2016 Financial Results
PR Newswire - Fri Apr 22, 5:00PM CDT
Tower International, Inc. (NYSE: TOWR), a leading global manufacturer of engineered automotive structural metal components and assemblies, will report first quarter 2016 financial results before the market opens on Thursday, Apr. 28, 2016, via PR Newswire. At 1:00 p.m. EDT on that date, a conference call is scheduled to discuss the results in further detail, as well as other related matters.
TOWR: 22.03 (-0.09)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading